NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Search Results for Methylphenidate


Filter Articles: Clinical News | Consumer News | Business News | All News | More Options

Results 1 - 20      Next >


Refine Search
Display Mode: Context | Summary
CONCERTA in the Classroom: New Data on Attention in Children With ADHD
2009 NOV 16 ... New findings presented today show that CONCERTA® (OROS® methylphenidate HCl Extended-Release Tablets CII) is the only stimulant medication with data that ...
Subject: McNeil Pediatrics
Price: $3.00
*
CONCERTA(R) (methylphenidate HCI) LAUNCHES MOBILE WEB EXPERIENCE TO PROVIDE TOOLS AND SUPPORT FOR ADHD AWARENESS
2009 SEP 21 ... Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc. and makers of CONCERTA (methylphenidate HCI), approved for treatment of ADHD in children and adults, is providing an innovative ...
Subject: Attention Deficit Hyperactivity Disorder
Price: $3.00
*
CONCERTA(R) in the Classroom: New Data on Attention in Children With ADHD
2009 NOV 16 ... New findings presented today show that CONCERTA=AE (OROS=AE methylphenidate HCl Extended-Release Tablets CII) is the only stimulant medication with data that ...
Subject: Pediatrics
Price: $3.00
*
Data on rehabilitation research discussed by researchers at Monash University
2009 AUG 10 ... "The aim of the present study was to evaluate the safety of methylphenidate administered during inpatient rehabilitation following traumatic brain injury. Forty ...
Subject: Rehabilitation Research
Price: $3.00
*
Findings from Firat University, Department of Psychiatry advance knowledge in attention deficit hyperactivity disorder
2009 OCT 5 ... diagnosed and treated for bipolar disorder for 6 years." "At that point, methylphenidate was initiated. The patient was judged to be a good treatment responder with improvements ...
Subject: Attention Deficit Hyperactivity Disorder
Price: $3.00
*
New data from University of Sydney illuminate research in medical ethics
2009 NOV 5 ... "Reports in the popular press suggest that smart drugs or ''nootropics'' such as methylphenidate, modafinil and piracetam are increasingly being used by the healthy to augment cognitive ...
Subject: Medical Ethics
Price: $3.00
*
New Higher Dose of Focalin XR(R) Improves Control of ADHD Symptoms for Up to 12 Hours
2009 NOV 16 ... since the drug may aggravate these symptoms; in patients known to be hypersensitive to methylphenidate or other components of the product; in patients with glaucoma; in patients with motor ...
Subject: Pediatrics
Price: $3.00
*
Recent findings in molecular imaging described by researchers from Tri-Service General Hospital
2009 JUL 28 ... windows were used for single-isotope imaging. Oral fluoxetine (20 mg) and intravenous methylphenidate HCl (1 mg/kg) were given 24 h and 10 min, respectively, before dual-isotope SPECT to ...
Subject: Molecular Imaging
Price: $3.00
*
Reports from University of Pittsburgh add new data to research in life sciences
2009 AUG 24 ... New investigation results, 'Controlled cortical impact injury influences methylphenidate-induced changes in striatal dopamine neurotransmission,' are detailed in a study ...
Subject: Life Sciences
Price: $3.00
*
Research from C. Forlini and co-authors yields new data on bioethics
2009 NOV 16 ... published in the journal BMC Medical Ethics, "There is substantial evidence that methylphenidate (MPH; Ritalin), is being used by healthy university students for non-medical motives ...
Subject: Bioethics
Price: $3.00
*
Research from Schneider Children's Medical Center, Department of Neurology in the area of hallucinations described
2009 AUG 24 ... A new study, 'Methylphenidate induction of complex visual hallucinations,' is now available. "A 15-year-old boy with ...
Subject: Hallucinations
Price: $3.00
*
Researchers from Nagoya University, Medical Department provide details of new studies and findings in the area of anxiety disorders
2009 AUG 10 ... on emotional behaviors and cognitive function in mice. Furthermore, the effects of methylphenidate (MPH), clozapine (CLZ)and fluoxetine (FIX) on SI-induced behavioral changes were ...
Subject: Anxiety Disorders
Price: $3.00
*
Scientists at Ruhr University publish new data on attention deficit hyperactivity disorder
2009 AUG 3 ... Bochum, Germany, "Self-efficacy of adults with ADHD might be changed unfavourably under methylphenidate treatment. Therefore, we sought to investigate the initial situation and changes under ...
Subject: Attention Deficit Hyperactivity Disorder
Price: $3.00
*
Scientists at University of Ulm describe research in attention deficit hyperactivity disorder
2009 OCT 19 ... for the treatment of attention-deficit hyperactivity disorder (ADHD) in adults advocate methylphenidate as first-line treatment. The aim of this study was to review the effectiveness of...
Subject: Attention Deficit Hyperactivity Disorder
Price: $3.00
*
Shire Reports Tolerability and Clinical Effects Results of Daytrana(R) (methylphenidate transdermal system) from Study in Adolescents with ADHD
2009 NOV 16 ... meeting from a Phase IIIb study of the tolerability and effectiveness of Daytrana=AE (methylphenidate transdermal system) in adolescents aged 13 to 17 years diagnosed with ...
Subject: Tics
Price: $3.00
*
Shire to Present Important Study Findings on its ADHD Treatments at a Major Psychiatric Meeting on October 29 and 30
2009 NOV 9 ... Release Tablets, Vyvanse=AE (lisdexamfetamine dimesylate) Capsules CII, and Daytrana=AE (methylphenidate transdermal system) CII, at a national meeting of psychiatrists to be held October 27 - ...
Subject: Attention Deficit Hyperactivity Disorder
Price: $3.00
*
Study results from J.A. Bethancourt and colleagues update understanding of attention deficit hyperactivity disorder
2009 AUG 10 ... According to recent research from Panama, "Methylphenidate (MPH) is the most commonly prescribed medication used to treat the symptoms associated ...
Subject: Attention Deficit Hyperactivity Disorder
Price: $3.00
*
Study results from Maastricht University in the area of life sciences published
2009 NOV 2 ... of the stimulant effect of fexofenadine with those of 2 psychostimulants, modafinil and methylphenidate. Sixteen healthy volunteers (5 males and 11 females; mean age, 21.8 years) participated ...
Subject: Life Sciences
Price: $3.00
*
Study results from University of Texas, M.D. Anderson Cancer Center broaden understanding of cancer prevention
2009 NOV 23 ... and acupuncture. Pharmacologic interventions include stimulants, namely modafinil and methylphenidate. In some patients antidepressants may be beneficial," wrote C.P. Escalante and ...
Subject: Cancer Prevention
Price: $3.00
*
Tel-Aviv University publishes research in attention deficit hyperactivity disorder
2009 AUG 10 ... lipids profile and their metabolism, with carbamazepine being the best known among them. Methylphenidate is a piperidine derivative structurally related to amphetamines and acts as a central ...
Subject: Attention Deficit Hyperactivity Disorder
Price: $3.00
*

Results 1 - 20      Next >




-----------------------
PR Login